Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia

Antimicrob Agents Chemother. 2013 Feb;57(2):1101-2. doi: 10.1128/AAC.01666-12. Epub 2012 Dec 10.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / genetics*
  • Colombia
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Female
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / microbiology*
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / genetics*
  • Klebsiella pneumoniae / isolation & purification
  • Meropenem
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / microbiology*
  • Stroke
  • Thienamycins / therapeutic use
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Thienamycins
  • beta-Lactamases
  • beta-lactamase KPC-2, Klebsiella pneumoniae
  • carbapenemase
  • Meropenem